FGF-23 Suppressibility by Calcitonin

Hypophosphatemia

Fibroblast growth factor - 23, Calcitonin

Introduction: Based on our experience with calcitonin as an FGF-23 suppressive agent in a patient with an FGF-23 producing tumor we hypothesize that calcitonin may be a physiologically important regulator of FGF-23 production and secretion in healthy humans. Aim: In this study we wish to examine the FGF-23 suppressive effects of calcitonin in healthy men. Study Design: placebo-controlled, cross-over study Method: * All twelve subjects are examined on two occasions, once after exposure to placebo 1 ml NaCl 0.9% subcutaneously, and once following calcitonin 200 IU/ml subcutaneously * On both occasions frequent bloodsampling will take place, out an indwelling catheter in de forearm vein. * Sampling times: -15, 0, 60, 120, 240, 360, and 480 minutes * Mealtimes: Calcium and Phosphate intake standardized on both occasions * All samples are analyzed for FGF-23, using a C-terminal FGF-23 ELISA kit (Immunotopics, San Clemente, USA) that measures intact and C-terminal fragments of FGF-23, and one that measures only intact FGF-23 * Samples obtained at T-15, T0, T240 and T480 are stored for later analysis of Ca, albumin, PO4, PTH, 25-OHD and 1,25-OHD Endpoint: A change of 25% in de serum FGF-23 levels in response to a single subcutaneous injection of calcitonin 200 IU.

No related papers found yet.

Papers published before 2007-09-01 may not appear yet. Historical indexing is in progress.

Netherlands